Marshall Wace North America’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-41,231
| Closed | -$608K | – | 1561 |
|
2020
Q2 | $608K | Buy |
41,231
+4,624
| +13% | +$68.2K | ﹤0.01% | 883 |
|
2020
Q1 | $494K | Buy |
+36,607
| New | +$494K | ﹤0.01% | 756 |
|
2019
Q4 | – | Sell |
-2,203
| Closed | -$42K | – | 1702 |
|
2019
Q3 | $42K | Buy |
+2,203
| New | +$42K | ﹤0.01% | 1181 |
|
2019
Q2 | – | Sell |
-95,578
| Closed | -$4.54M | – | 1759 |
|
2019
Q1 | $4.54M | Buy |
95,578
+16,405
| +21% | +$779K | 0.03% | 342 |
|
2018
Q4 | $2.86M | Buy |
79,173
+27,651
| +54% | +$998K | 0.03% | 360 |
|
2018
Q3 | $3.17M | Sell |
51,522
-46,106
| -47% | -$2.84M | 0.02% | 403 |
|
2018
Q2 | $6.6M | Buy |
+97,628
| New | +$6.6M | 0.04% | 445 |
|
2018
Q1 | – | Sell |
-28,206
| Closed | -$1.69M | – | 1782 |
|
2017
Q4 | $1.69M | Buy |
28,206
+7,790
| +38% | +$465K | 0.01% | 879 |
|
2017
Q3 | $1M | Buy |
+20,416
| New | +$1M | 0.01% | 947 |
|